Picture of Abionyx Pharma SA logo

ABNX — Abionyx Pharma SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapSucker Stock

Brief: ABIONYX Pharma Announces Subscription Of Equity-Linked Facility With IRIS

May 24 (Reuters) - Abionyx Pharma Sa  ABNX.PA :
    * ANNOUNCED ON TUESDAY ACCELERATES ITS DEVELOPMENT BY
LAUNCHING A
NEW BIOMANUFACTURING CAMPAIGN BASED ON THE RECENTLY ANNOUNCED
ROBUST INNOVATIVE PROCESS SUPPORTED BY AN EQUITY-LINKED
FINANCING FACILITY
    * SUBSCRIPTION OF EQUITY-LINKED FINANCING FACILITY FOR UP TO
EUR
12 MILLION WITH IRIS

Source text for Eikon:  ID:nBw8VyC2ha 
Further company coverage:  ABNX.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Abionyx Pharma SA

See all news